uk en
LIFE SCIENCES LAWYERS | UKRAINE & CIS
Menu

LA LAW FIRM (Legal Alliance) founded in 1995, is today one of the leading Ukrainian law firms that provides comprehensive corporate counselling and practical support to national and global companies in Ukraine, СEE & Central Asia.

OUR CLIENTS represent life sciences industries including healthcare and pharmaceuticals, medical devices, cosmetics, biotechnology as well as healthcare institutions.

LEADING ASSOCIATIONS — AIPM Ukraine, APRaD as well as the EBA Healthcare Committee have chosen LA Law Firm as their legal advisor.

261

Webinar: NEW LEGISLATION – NEW RULES. The New Law of Ukraine "On Medicinal Products" effective January 1, 2027

June 24-25, 2026

10:30-13:30 ONLINE ZOOM

Prepare for the Shifting Pharmaceutical Landscape: Ukraine’s New Law on Medicinal Products is on the Horizon!

Ukraine’s pharmaceutical market is on the verge of large-scale legislative transformation. Are you prepared to operate under the new regulations, which will take effect on January 1, 2027?

We invite you to a two-day expert webinar hosted by LA Law Firm, where we will provide an in-depth analysis of the key changes, risks, and business opportunities within this new regulatory reality.

Why should you participate?

You will gain structured insights into the transition period, as well as the new requirements for the import, manufacturing, and circulation of medicinal products. We will go beyond a simple overview of the law – we will provide actionable recommendations on how to adapt your business processes to prevent violations and ensure business continuity.

Speakers to be invited: Representatives of the State Expert Center (SEC) on practical implementation of the new Law of Ukraine "On Medicinal Products."


AGENDA

10:30-12:45 | TOPICS TO BE DISCUSSED

  1. Terminology. New terms in pharmaceutical market regulation.
  2. Marketing Authorization of Medicinal Products. Grounds for suspension, cancellation, and termination of registration.
  3. The Marketing Authorization Holder Representative in Ukraine. New: Legal entities or Individual Entrepreneurs (FOP).
  4. Good Practices. GMP (Good Manufacturing Practice) certification and confirmation.
  5. Bioequivalence. Data Updates. Registration Dossier Compliance.
  6. Importation of Medicinal Products. From EU and SRA countries vs. other nations. Quality control upon import. The Importer’s Authorized Person. Responsibility.
  7. Manufacturing of Medicinal Products. New: Requirements for contract manufacturing.
  8. Wholesale and Retail Trade.
  9. The Ukrainian Pharmaceutical Agency. Powers, audits, and inspections.
  10. Prohibition of Circulation of Medicinal Products.
  11. Pharmacovigilance. Procedures and new requirements.
  12. Advertising and Promotion. Restrictions on personnel authorized to conduct promotional activities.
  13. Verification of Medicinal Products. Mandatory requirements effective January 1, 2028.
  14. Transition Period: Aligning registration dossiers regarding bioequivalence confirmation with the new Law.
  15. Market Entry Deadline. Medicinal products registered under the old Law that do not meet the new requirements: transition period. Recommendations for subsequent actions.
  16. Analysis of the bylaws under the new Law, to be published for public discussion.

12:45-13:30 | Q&A SESSION


SPEAKERS

Dmytro Aleshko, Moderator, Managing Partner, LA Law Firm

Lidiia Sanzharovska, Associate Partner, LA Law Firm


INFORMATION & REGISTRATION

Participation fee: 17 800 UAH (2-day online access).

LA Law Firm current clients and member companies of partner associations receive a 10% discount.

Registration and mass media accreditation are mandatory:

Language: Ukrainian.

Should you have any questions regarding registration and participation, please contact at news@l-a.com.ua or on the phone +380 67 445 7784 Natalia, +380 67 710 9707 Tetiana.

After registration, each participant is given individual ZOOM access to an online webinar.


Registration

If you find out a mistake, please, mark it and select Ctrl+Enter to inform us